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Background: Accurate, continuous heart rate measurements are important for health assessment, physical activity, and sporting
performance, and the integration of heart rate measurements into wearable devices has extended its accessibility. Although the
use of photoplethysmography technology is not new, the available data relating to the validity of measurement are limited, and
the range of activities being performed is often restricted to one exercise domain and/or limited intensities.
Objective: The primary objective of this study was to assess the validity of the Polar OH1 and Fitbit Charge 3 devices for
measuring heart rate during rest, light, moderate, vigorous, and sprint-type exercise.
Methods: A total of 20 healthy adults (9 female; height: mean 1.73 [SD 0.1] m; body mass: mean 71.6 [SD 11.0] kg; and age:
mean 40 [SD 10] years) volunteered and provided written informed consent to participate in the study consisting of 2 trials. Trial
1 was split into 3 components: 15-minute sedentary activities, 10-minute cycling on a bicycle ergometer, and incremental exercise
test to exhaustion on a motorized treadmill (18-42 minutes). Trial 2 was split into 2 components: 4 × 15-second maximal sprints
on a cycle ergometer and 4 × 30- to 50-m sprints on a nonmotorized resistance treadmill. Data from the 3 devices were time-aligned,
and the validity of Polar OH1 and Fitbit Charge 3 was assessed against Polar H10 (criterion device). Validity was evaluated using
the Bland and Altman analysis, Pearson moment correlation coefficient, and mean absolute percentage error.
Results: Overall, there was a very good correlation between the Polar OH1 and Polar H10 devices (r=0.95), with a mean bias
of −1 beats·min-1 and limits of agreement of −20 to 19 beats·min-1. The Fitbit Charge 3 device underestimated heart rate by 7
beats·min-1 compared with Polar H10, with a limit of agreement of −46 to 33 beats·min-1 and poor correlation (r=0.8). The mean
absolute percentage error for both devices was deemed acceptable (<5%). Polar OH1 performed well across each phase of trial
1; however, validity was worse for trial 2 activities. Fitbit Charge 3 performed well only during rest and nonsprint-based treadmill
activities.
Conclusions: Compared with our criterion device, Polar OH1 was accurate at assessing heart rate, but the accuracy of Fitbit
Charge 3 was generally poor. Polar OH1 performed worse during trial 2 compared with the activities in trial 1, and the validity
of the Fitbit Charge 3 device was particularly poor during our cycling exercises.
(JMIR Mhealth Uhealth 2021;9(3):e25313) doi: 10.2196/25313
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Introduction
Background
Consumer wearables constitute an ever-evolving industry with
applications across multiple sectors of society. One key demand
for wearable technology is to monitor and use parameters
associated with physical activity for sport performance, health,
and well-being. For example, a recent systematic review and
meta-analysis concluded that the utilization of a consumer-based
wearable activity tracker, used either as the primary component
of an intervention or as part of a broader physical activity
intervention, has the potential to increase participation in
physical activities [1].
The autonomic nervous system (ANS) is interlinked with many
physiological systems, and heart rate (HR) measures are
considered surrogate markers of ANS status [2,3]. Exercise
training stimulates ANS status changes, and HR measures
therefore reflect physiological responses related to training
adaptations [4]. HR monitoring enables noninvasive,
cost-effective, and continuous insights into exercise intensity
[5]. This may be important for optimizing training responses
and for safety considerations (eg, restricting exercise intensity
because of contraindications associated with an elevated HR).
Wrist-worn, optical HR sensors using photoplethysmography
(PPG) technology are exciting, as they reduce the requirement
for chest strap or electrocardiogram (ECG) device use. ECG
devices are inconvenient, can cause discomfort, and may be
time-consuming to use, potentially providing a barrier to
participation and optimal training. Although the use of PPG
technology is not new in devices, the range of activity types
and intensities being performed in validation studies is often
restricted. Despite the widely adopted use of PPG in wearable
devices, the standards of accuracy and reliability outside of
medical devices can be poor, technology frequently advances,
and new products are continuously released. Furthermore, the
algorithms adopted by companies to derive HR from raw PPG
signals are constantly changing, thereby affecting the validity
of wearable devices for measuring HR. It is therefore important
that devices are continually subjected to scientific scrutiny for
appropriate interpretation and advice to be provided.
Polar OH1 (Polar Electro Oy) and Fitbit Charge 3 (Fitbit Inc)
are two of the latest available devices that use PPG technology.
They differ in that the Fitbit device constitutes a watch worn
on the wrist, whereas Polar OH1 may be worn on either the
forearm or the temple and is a stand-alone optical HR sensor.
It has previously been shown that Polar OH1 is accurate at
measuring HR during moderate-intensity yoga compared with
a Polar H7 chest strap (mean bias: −0.76 beats·min-1; 95% limits
of agreement [LoAs]: −3.83 to 5.35 beats·min-1) [6] and during
moderate-to-high intensity treadmill and spin bike exercise
compared with ECG (forearm sensor aggregated data mean
bias: 0.27 beats·min-1; LoAs: −4.68 to 5.22 beats·min-1) [7].
Conversely, although the validity of Fitbit Charge 2 has
previously been assessed [8,9], we are unaware of any study
assessing the validity of Fitbit Charge 3. Fitbit Charge 3 was
released in 2018 as an upgrade to the subsequently discontinued
Fitbit Charge 2; however, despite Fitbit Charge 2 demonstrating
poor HR measurement accuracy at higher workloads [8,10] and
during cycling [9,11], HR monitoring technology appears
unchanged. Furthermore, limited data are available for a range
of exercise types and intensities. Specifically, there are currently
no studies that have assessed PPG HR validity during sprint
interval exercise (SIE), defined as exercise bouts performed in
an all-out manner or at an absolute intensity that exceeds the
workload required to elicit maximal oxygen uptake, with each
bout separated by a recovery interval [12]. This may be
particularly pertinent given the current popularity of SIE and
high-intensity interval exercise (HIIE), which is commonly
defined as relatively intense bouts of exercise that elicit ≥80%
of maximal HR, interspersed with recovery periods [12]. Several
studies examining the validity of commercial wearable devices
have reported an increase in HR measurement error as exercise
intensity increases [8,9,13,14]. This has been attributed to
increased motion artifacts caused by rapid arm swinging during
running [13], although it has been suggested that sustained
isometric muscle contractions when gripping handlebars during
cycling may reduce contact between a wrist-worn device and
the skin [15]. In addition, during the initiation of exercise, HR
can change rapidly with a limited increase in forearm or wrist
blood flow to the skin [16]. Therefore, it is important to assess
the validity of HR measurements during different activities and
intensities. To our knowledge, no study has investigated the
accuracy of Polar OH1 or Fitbit Charge 3 across a range of
activity types and intensities.
Objectives
Therefore, the objective of this study was to assess the validity
of Polar OH1 and Fitbit Charge 3 for measuring HR during rest,
cycling, walking, and running activities. Validity during cycling,
walking, and running activities was assessed across a range of




A total of 20 healthy adults (9 female; height: mean 1.73 [SD
0.1] m; body mass: mean 71.6 [SD 11.0] kg; fat mass: mean
17.0% [SD 7.8%]; age: mean 40 [SD 10] years; and International
Physical Activity Questionnaire-Short Form [IPAQ-SF] [17]
Physical Activity Category: high=20, moderate=0, and low=0)
volunteered and provided written informed consent to participate
in the study. Inclusion criteria were age between 18 and 60 years
and categorized as having moderate-to-high levels of physical
activity (as determined by the IPAQ-SF). Exclusion criteria
were categorized as having low levels of physical activity (as
determined by the IPAQ-SF), a noncommunicable disease (eg,
cardiovascular disease, cancer, and respiratory disease),
musculoskeletal injury in the past 2 months, and illness in the
previous 6 weeks. One female participant withdrew from the
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study at visit 1 because of injury (n=19). All the remaining
participants completed visit 1 (n=19); however, 1 female
participant was unable to complete visit 2 because of illness
(n=18), and 1 male participant was unable to complete the visit-2
treadmill sprints because of injury (treadmill sprints; n=17).
Ethical approval was provided by the University Ethics
Committee at the University of the Highlands and Islands
(OL-ETH-SHE-1436). All procedures were conducted in
accordance with the Declaration of Helsinki 1974 and its later
amendments. Written informed consent was obtained from all
volunteers before entering the study, and the participants could
withdraw at any point.
Study Design
The study consisted of 2 visits to the Active Health Exercise
Laboratory at the University of the Highlands and Islands,
Inverness, which were conducted a minimum of 3 days apart.
Participants were asked to refrain from intense physical activity
(24 h), alcohol (12 h), caffeine (6 h), and food (3 h) before
arrival at the laboratory for each visit. During visit 1, participants
completed 15 minutes of sedentary activities, 10 minutes of
cycling, and a treadmill protocol. For visit 2, each participant
completed cycling and treadmill-based HIIE protocols. During
each of the trials, participants’HRs were continuously monitored
by a Polar H10 heart rate monitor (Polar Electro Oy; criterion
measure), Polar OH1, and Fitbit Charge 3.
Devices
Polar H10 HR Monitor
Polar H10 was used as the criterion device. The HR sensor was
attached to a Polar Pro heart rate strap placed over the sternum.
Polar H10 live data were transmitted to a spiroergometry system
(METALYZER 3B, CORTEX Biophysik GmbH), which
recorded HR data at 1-second intervals. Polar H10 has
previously been found to be valid when compared with ECG,
with a correlation of r=0.997 [18].
Polar OH1
Polar OH1 was attached to an arm band and strapped securely
to the nondominant forearm, according to the manufacturer’s
instructions. HR data were recorded at 1-second intervals using
6 light-emitting diode sensors and live transmitted via Bluetooth
to a smartphone with the Polar Beat app (Polar Electro Oy).
After completion of each visit, data were uploaded to the Polar
Flow web service (Polar Electro Oy).
Fitbit Charge 3
Fitbit Charge 3 was attached to the nondominant wrist, 2-finger
widths above the ulnar styloid process, following the
manufacturer’s instructions. According to the manufacturer,
Fitbit Charge 3 uses PurePulse wrist HR technology to measure
HR. Data were synced to an anonymized Fitbit account, and
subsequently, the intraday second-by-second data were exported




Upon arrival at the laboratory, participants were briefed on the
protocol before anthropometric variables were measured. Height,
body mass, and body composition were measured with
participants wearing light exercise clothing. Height was
measured to the nearest 0.1 cm using a portable stadiometer
(Model 213, Seca), body mass was measured to the nearest 0.1
kg using a floor scale (Model 875, Seca), and body composition
was assessed using bioelectrical impedance (MC780MA, Tanita
Corporation). The HR measuring devices were subsequently
attached as described above.
The trial was split into 3 components. Component 1 consisted
of 15 minutes of sedentary activities. The participants remained
seated in a chair for the duration of component 1 and were
instructed to keep their movement to a minimum. During the
first 5 minutes, participants sat quietly before watching 5
minutes of a nature documentary. All participants watched the
same 5-minute section of the documentary. Finally, the
participants completed a cognitive task where they were
provided with a choice of either a word search, crossword, or
sudoku puzzle and were instructed to complete as much as
possible within the time frame. Before component 2, a target
HR range was calculated to determine 60%-85% of HR reserve
target intensity using the equation:
Target HR = Percentage target intensity ×
(age-predicted max HR − resting HR) + resting HR
Resting HR was calculated as an average of the final minute of
sitting quietly, whereas the age-predicted maximum HR was
calculated using the following formula by Gellish et al [20]:
Age-predicted max HR = 206.7 − (0.67 × age).
Component 2 consisted of 10-minute cycling on a bicycle
ergometer (Lode Corival). During the cycling tasks, each
participant completed 5 minutes of light work at 50 W. After 5
minutes, the intensity was increased to substantially elevate HR
to between 60% and 85% of the HR reserve. Between
components 2 and 3, participants rested for a minimum of 10
minutes.
Component 3 consisted of an incremental exercise test on a
motorized treadmill (Skillrun, Technogym). The treadmill test
consisted of a range of intensities from light to high intensity,
increasing at 3-minute intervals until volitional exhaustion. The
initial phase of each test was continuous, beginning with walking
at speeds of 4, 5, and 6 km·h-1 and then running at speeds of 8
and 10 km·h-1 at 1% gradient for 3 minutes. For those who were
able to continue, a subsequent discontinuous phase of the test
immediately followed the continuous phase. The discontinuous
phase consisted of running for 3 minutes at 12, 14, 16, and 18
km·h-1 (or until volitional exhaustion), with each stage separated
by 3 minutes of active recovery (walking at 4 km·h-1). The
discontinuous phase was used to allow the participants to
complete as many stages as possible. Participants were not
required to complete all stages to be included in the analysis.
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Upon arrival at visit 2, the devices were attached to the
participants, as described in visit 1. Visit 2 was split into 2
components. Component 1 consisted of a 3-minute warm-up
followed by 4 maximal sprints, each lasting 15 seconds and
interspersed with 3-minute active recovery on a cycle ergometer
(Wattbike Pro, Wattbike). The airbrake resistance was set at 1
during the warm-up and active recovery phases and was
increased based on body mass, as per the manufacturer’s
guidelines (Multimedia Appendix 1), immediately before each
sprint. Following the completion of a 3-minute active cooldown,
participants were instructed to rest for 30 minutes before
commencing component 2.
Component 2 was performed using the Technogym Skillrun
treadmill’s parachute training mode, which is a nonmotorized
program and whose objectives are based on distance, not
duration. In addition, treadmill belt resistance is adjusted by
changing the parachute size, which ranges from extra small
(lowest resistance setting) to extra large (highest resistance
setting); however, the resistance that each parachute size pertains
to has not been quantified by Technogym. For the purposes of
this study, the distance to be covered was selected based on the
final velocity of the incremental treadmill test at visit 1
(Multimedia Appendix 2), and the treadmill belt resistance was
set based on body mass (Multimedia Appendix 3). Participants
self-propelled the treadmill belt and were secured to the
treadmill using a harness worn around their waist. Before
starting the repeated sprint protocol, participants completed 400
m on the treadmill at a self-selected pace, with belt resistance
at the lowest setting, to act as a familiarization and warm-up.
They were then given the opportunity to perform the stretching
exercises. The sprints consisted of 4 repetitions, each lasting
approximately 15 seconds (range 13-18 s). It was anticipated
that the duration of each sprint would last approximately 15
seconds to match the sprint cycling trial, as it is not possible to
complete a parachute test on the treadmill in a time setting.
Following each sprint, the treadmill was set to a motorized
setting of 4 km·h-1 and 1% gradient for 3 minutes of active
recovery.
Data Analysis
Data from the 3 devices were time-aligned and split into the
following parts:
• Visit 1: rest, light cycling, vigorous cycling, and treadmill
• Visit 2: sprint cycling and sprint running
The validity of Polar OH1 and Fitbit Charge 3 was compared
with the validity of Polar H10 (criterion device) for all data
points and as an average HR for each segment. Data alignment
and filtering were performed in R Studio using the packages
dplyr and tidr. Before analysis, the normality of data was
assessed using histograms and quantile-quantile plots. Validity
was subsequently evaluated using the Bland and Altman [21]
analysis. Secondary measures, including the Pearson moment
correlation coefficient and mean absolute percentage error
(MAPE), are also provided. The Bland and Altman [21] analysis
was used to express agreement between the measured and
predicted beats per minute, where 95% LoA was calculated as
mean bias (1.96SD). We deemed a MAPE of 0%-5% to be
within the acceptable limits, a commonly adopted approach
[9,22]. Correlation coefficients were interpreted as very poor
(r<0.69), poor (r=0.70-0.84), good (r=0.85-0.94), very good
(r=0.95-0.994), and excellent (r>0.995). The MAPE was
calculated using the following equation, which provided a
general measurement error for the monitors:
MAPE=((monitor−criterion)/criterion100)
Results
Validity of HR Across All Data
Combined data across all activity types showed that Polar OH1
underestimated HR by 1 beat·min-1 (LoA: −20 to 19 beats·min-1)
versus the Polar H10 device, and there was a very good
correlation between the devices (r=0.957; Table 1). The Fitbit
device underestimated the HR by 7 beats·min-1 (LoA: −46 to
33 beats·min-1; Table 1). Overall, there was a good correlation
between Fitbit Charge 3 and Polar H10 (r=0.807), and the
MAPE for both devices was deemed acceptable (Table 1). In
addition, aggregated HR data for each activity domain revealed
results similar to those of the unaveraged data analysis (Table
2).
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Table 1. Validity of measuring heart rate with the Polar OH1 and Fitbit Charge 3 devices. Data are unaveraged across all data points (overall) and

















123 (19)131 (25)124 (31)119 (16)89 (12)63 (10)114 (33)Heart rate (beats·min-1),
mean (SD)
Polar OH1
125 (20)125 (26)124 (30)118 (17)89 (12)63 (10)113 (33)Heart rate (beats·min-1),
mean (SD)
2−60−110−1Mean bias (beats·min-1)








95% CI of correlation
coefficient
Fitbit Charge 3
114 (16)111 (30)123 (27)98 (24)81 (12)62 (9)107 (31)Heart rate (beats·min-1),
mean (SD)
−10−20−1−21−7−1−7Mean bias (beats·min-1)








95% CI of correlation
coefficient
 
an: number of data points analyzed for each domain.
bMAPE: mean absolute percentage error.
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Table 2. Validity of measuring heart rate with Polar OH1 and Fitbit Charge 3 devices. Data are aggregated to a single data point for each of the activity

















120 (12)128 (17)124 (14)119 (12)89 (11)62 (9)106 (27)Heart rate (beats·min-1),
mean (SD)
Polar OH1
121 (15)122 (17)124 (14)118 (12)89 (10)62 (9)105 (27)Heart rate (beats·min-1),
mean (SD)
1501001Mean bias (beats·min-1)




0.651 to 0.6870.795 to 0.8190.992 to
0.993




95% CI of correlation coef-
ficient
Fitbit Charge 3
112 (11)109 (23)123 (10)100 (21)81 (10)61 (9)97 (26)Heart rate (beats·min-1),
mean (SD)
−8−18−2−19−7−1−9Mean bias (beats·min-1)




0.471 to 0.5200.756 to 0.7840.921 to
0.927




95% CI of correlation coef-
ficient
an: number of data points analyzed for each domain.
bMAPE: mean absolute percentage error.
Validity of HR for Each Activity Type
The mean bias and LoA for Polar OH1 and the criterion device
were consistent for visit 1 activities; however, the LoA was
much wider during HIIE exercise (Figure 1). Similarly, Polar
OH1 performed consistently across each segment of visit 1,
with very low MAPE and a very good correlation (Table 1).
The MAPE and correlation coefficients were worse during HIIE
activities (Table 1; Figure 1). Fitbit Charge 3 performed well
with a low MAPE (<5%) and had a good correlation during the
rest and treadmill activities. Although the MAPE was low for
sprint cycling and sprint running, the correlation was poor (Table
1). Validity was poor during light cycle exercise (r=0.272;
MAPE=−7.1%) and was very poor during vigorous cycling
(r=0.183; MAPE=−16.4%). The mean bias ranged from −21 to
−1 beats·min-1 and, together with the LoA, are depicted in Figure
1. Validity across participants was consistent for OH1, where
the MAPE was <5% for each participant (Table 3). The MAPE
for each participant for Fitbit Charge 3 exceeded 5% in 7 of 19
participants (Table 3). Individual traces for each of the 3 devices
during sprint cycling are shown in Figure 2.
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Figure 1. Bland and Altman plots for unaveraged data across each activity domain. Subpart A shows data from Polar OH1, and subpart B shows data
from Fitbit Charge 3. Solid blue line represents the mean bias, and blue dashed lines represent the limits of agreement.
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Table 3. The mean absolute percentage error for each participant for Polar OH1 and Fitbit Charge 3 across all available data points.





















aExceeds 5% mean absolute percentage error threshold.
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Figure 2. Individual traces during sprint cycling. Green line represents Polar H10 (criterion device), the blue line represents Polar OH1, and the red
line represents Fitbit Charge 3. Traces show 4 peaks in heart rate for each of the sprints followed by a recovery period of 3 minutes.
Discussion
Principal Findings
To our knowledge, this is the first study to assess the validity
of Fitbit Charge 3 and Polar OH1 across a range of activity
types, including HIIE or SIE. The main findings were that Polar
OH1 showed good agreement in assessing HR versus the
criterion measure (Polar H10) across activity domains or types
in trial 1, whereas the validity of Fitbit Charge 3 was only
acceptable during rest and treadmill activities. Fitbit Charge 3
performed particularly poorly during cycling exercise, where
the mean bias ranged from −7 to −21 beats·min-1, and LoA were
very wide compared with other activity types. Finally, our data
suggest that both Polar OH1 and Fitbit Charge 3 devices
performed poorly during the visit 2 sprint cycling and sprint
running protocols compared with the visit 1 activities.
The findings in this study suggest that Polar OH1 performs
within acceptable tolerance limits for measuring HR during a
range of activity types and intensities (ie, MAPE range 0%-4%).
These findings are consistent with those of previous work [7].
Despite this, our data suggest that OH1 may be less capable of
accurately measuring HR during sprint-based exercise.
Figure 2 shows the individual responses to sprint cycling for
each of the 3 devices. Polar OH1 followed a similar trend to
Polar H10 in 13 of the 18 available data sets. In contrast, Fitbit
Charge 3 only followed a similar profile to Polar H10 in 5 of
the 18 participant data sets. A typical observation across
participants was a lower peak HR versus the criterion device
and a slower response in HR change following the onset of
sprint work. Given the popularity of HIIE and SIE training,
these limitations may be crucial for assessing intensity
accurately, and further development of the technology is
required before it can be used accurately instead of ECG-type
devices across all activity types. For everyday activities and for
measuring HR in a range of activities, PPG-type devices may
therefore be a more practical solution for estimating the intensity
of activities. This may be particularly relevant in older,
overweight or obese, or clinical populations, where wearing a
chest strap may be off-putting or impractical.
This is the first published study to examine the validity of Fitbit
Charge 3, although several studies have investigated the validity
of its predecessors, Fitbit Charge HR (released 2015) and Fitbit
Charge 2 (released 2016). We observed HR measurements that
were within an acceptable percentage error range (0%-5%)
during rest and the incremental treadmill test. However, Fitbit
Charge 3 exhibited MAPE >5% during sprint running and during
light, hard, and sprint cycling, with particularly large MAPE
and mean bias observed during hard and sprint cycling. Previous
studies have reported that Fitbit Charge HR and Fitbit Charge
2 underestimate HR in comparison with criterion devices during
cycle-based activities [8,9,11,14]. In addition, increasing
exercise intensity appears to increase Fitbit Charge HR and
Charge 2 measurement errors [8-10,14,23-25]. Furthermore,
Reddy et al [9] reported that Fitbit Charge 2 criterion-related
validity was poor during cycling when transitioning swiftly
from low to high intensity, which is in agreement with our
cycling SIE findings, suggesting that Fitbit Charge model
exhibits a measurement lag when HR increases rapidly.
Therefore, under the conditions of this study, Fitbit Charge 3
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performs as poorly as its predecessors when measuring HR
during cycling activities and high-intensity exercise.
We can only speculate as to why Fitbit Charge 3 performed
worse than Polar OH1 during cycling and high-intensity exercise
in this study. Olstad and Zinner [26] previously suggested that
wrist-based devices may be less sensitive to sudden changes in
exercise intensity, such as when transitioning from low to high
intensity, as experienced in SIE, because peripheral resistance
is lower at the wrist, reducing changes in pulse pressure and
disrupting blood pulse detection [16]. Therefore, the positioning
of Polar OH1 may partially mitigate the poor signal detected at
the wrist location. Furthermore, greater movement at the wrist
may contribute to poor measurement accuracy [8,9,27],
particularly during activities involving sustained hand and
forearm muscle contractions [15], as may be experienced when
gripping the handlebars during intense cycling. It is possible
that Polar OH1 is less prone to movement artifacts because of
a more robust strap design, which Spierer et al [15] previously
identified as a potential contributor to differences in HR
measurements among devices. In addition, Thomson et al [10]
stated that hardware differences may affect the signal-to-noise
ratio of the device. PurePulse technology of Fitbit Charge 3
may be more sensitive to interference than the technology of
Polar OH1, which could have resulted in the less accurate HR
measurements obtained in this study. Further advancements in
technology are inevitable and will require further work from
the scientific community to scrutinize devices and software
advancements. Nevertheless, PPG-based devices provide an
exciting opportunity to improve physical activity levels, promote
adherence to exercise interventions, and drive behavior change.
This study included a variety of exercise intensities and both
cycling and treadmill activities. In addition, few studies have
examined the validity of consumer wearables in measuring HR
during SIE, an increasingly prevalent exercise modality.
However, despite providing novel insights into the accuracy of
Fitbit Charge 3 and Polar OH1 in the detection of HR, this study
has limitations. The sample size of this study, which is consistent
with other similar studies [6,7,13,26,28-30], is small; therefore,
the elements of the study are likely underpowered. This is
particularly true for the HIIE type exercise, where a large
variation in HR is observed, which is far from zero. As a result,
it is inevitable that the associated LoAs are large and that a
larger sample size is required to reduce the variation in the
measurement. We refer readers to a new consensus statement
by Mühlen et al [31] for further reading regarding sample size
estimation for validation studies and for the design of validation
studies in general. Furthermore, given the significant effort and
time required to perform these types of studies, adequate funding
is required from manufacturers to appropriately address the
issue of sample size in validation studies. Other limitations
include that the exercise tasks were conducted in a controlled
laboratory environment, and the performance of these devices
may differ when investigated under free-living conditions. This
study, similar to many activity tracker validation studies, elected
to recruit a cohort of individuals who were healthy and young
to middle aged (25-56 years). Therefore, our findings cannot
be generalized to clinical populations or different age groups.
Furthermore, although not always the case [32], skin tone has
been found to affect PPG signals [33] but was not accounted
for in this study. Finally, our study design did not assess device
acceptability, which should be considered if these devices were
to be used in community-based interventions.
Conclusions
In conclusion, our data suggest that Polar OH1 is a suitable
method for measuring HR during cycling, walking, and running
activities within a healthy population. In contrast, data pertaining
to Fitbit Charge 3 should be interpreted with caution, particularly
during cycling activities. This may have significant implications
for exercise training or rehabilitation purposes, where attainment
of exercise intensity is a key aspect for cardiorespiratory fitness
progression or where safety considerations exist. Furthermore,
both PPG sensors evaluated in this study performed worse
during the SIE activities. Given the rise in popularity of HIIE
or SIE, we recommend that more traditional ECG/HR monitors
are used when performing these activities. For the general
population and scientific community to appropriately interpret
PPG data, researchers should continue to assess the validity of
new and existing devices among various populations and
settings.
Acknowledgments
The authors would like to thank all participants who volunteered to participate in this study. DM, OG, DC and IM are supported
by the European Union’s INTERREG VA Programme, managed by the Special European Union Programmes Body. DC is also
supported by a grant from Highlands and Islands Enterprise (HMS 9353763). KH is partly funded by a grant from Highlands and
Islands Enterprise (HMS 9353763) and partly funded by Inverness and Highland City-Region Deal.
Authors' Contributions
DM, TG, IM, and DC conceptualized the study. DM, KH, AD, and DC collected the data. DM and DC analyzed the data and





JMIR Mhealth Uhealth 2021 | vol. 9 | iss. 3 | e25313 | p. 10https://mhealth.jmir.org/2021/3/e25313
(page number not for citation purposes)
Muggeridge et alJMIR MHEALTH AND UHEALTH
XSL•FO
RenderX
[DOCX File , 305 KB-Multimedia Appendix 1]
Multimedia Appendix 2
Sprint running distance settings.
[DOCX File , 19 KB-Multimedia Appendix 2]
Multimedia Appendix 3
Sprint running treadmill belt resistance (parachute size) settings.
[DOCX File , 19 KB-Multimedia Appendix 3]
References
1. Brickwood KJ, Watson G, O'Brien J, Williams AD. Consumer-based wearable activity trackers increase physical activity
participation: systematic review and meta-analysis. JMIR Mhealth Uhealth 2019 Apr 12;7(4) [FREE Full text] [doi:
10.2196/11819] [Medline: 30977740]
2. Aubert AE, Seps B, Beckers F. Heart rate variability in athletes. Sports Med 2003;33(12):889-919. [doi:
10.2165/00007256-200333120-00003] [Medline: 12974657]
3. Borresen J, Lambert MI. Changes in heart rate recovery in response to acute changes in training load. Eur J Appl Physiol
2007 Nov 9;101(4):503-511. [doi: 10.1007/s00421-007-0516-6] [Medline: 17687564]
4. Buchheit M. Monitoring training status with HR measures: do all roads lead to Rome? Front Physiol 2014;5:73 [FREE Full
text] [doi: 10.3389/fphys.2014.00073] [Medline: 24578692]
5. Schneider C, Hanakam F, Wiewelhove T, Döweling A, Kellmann M, Meyer T, et al. Heart rate monitoring in team sports-a
conceptual framework for contextualizing heart rate measures for training and recovery prescription. Front Physiol 2018
May 31;9:639 [FREE Full text] [doi: 10.3389/fphys.2018.00639] [Medline: 29904351]
6. Schubert MM, Clark A, De La Rosa AB. The polar OH1 optical heart rate sensor is valid during moderate-vigorous exercise.
Sports Med Int Open 2018 Jun;2(3):E67-E70 [FREE Full text] [doi: 10.1055/a-0631-0920] [Medline: 30539120]
7. Hettiarachchi IT, Hanoun S, Nahavandi D, Nahavandi S. Validation of Polar OH1 optical heart rate sensor for moderate
and high intensity physical activities. PLoS One 2019 May 23;14(5) [FREE Full text] [doi: 10.1371/journal.pone.0217288]
[Medline: 31120968]
8. Boudreaux BD, Hebert EP, Hollander DB, Williams BM, Cormier CL, Naquin MR, et al. Validity of wearable activity
monitors during cycling and resistance exercise. Med Sci Sports Exerc 2018 Mar;50(3):624-633. [doi:
10.1249/MSS.0000000000001471] [Medline: 29189666]
9. Reddy RK, Pooni R, Zaharieva DP, Senf B, El Youssef J, Dassau E, et al. Accuracy of wrist-worn activity monitors during
common daily physical activities and types of structured exercise: evaluation study. JMIR Mhealth Uhealth 2018 Dec
10;6(12) [FREE Full text] [doi: 10.2196/10338] [Medline: 30530451]
10. Thomson EA, Nuss K, Comstock A, Reinwald S, Blake S, Pimentel RE, et al. Heart rate measures from the Apple Watch,
Fitbit Charge HR 2, and electrocardiogram across different exercise intensities. J Sports Sci 2019 Jun 18;37(12):1411-1419.
[doi: 10.1080/02640414.2018.1560644] [Medline: 30657025]
11. Benedetto S, Caldato C, Bazzan E, Greenwood DC, Pensabene V, Actis P. Assessment of the Fitbit Charge 2 for monitoring
heart rate. PLoS One 2018 Feb 28;13(2) [FREE Full text] [doi: 10.1371/journal.pone.0192691] [Medline: 29489850]
12. Weston KS, Wisløff U, Coombes JS. High-intensity interval training in patients with lifestyle-induced cardiometabolic
disease: a systematic review and meta-analysis. Br J Sports Med 2014 Aug 21;48(16):1227-1234. [doi:
10.1136/bjsports-2013-092576] [Medline: 24144531]
13. Khushhal A, Nichols S, Evans W, Gleadall-Siddall D, Page R, O'Doherty A, et al. Validity and reliability of the apple watch
for measuring heart rate during exercise. Sports Med Int Open 2017 Oct 18;1(6):206-211 [FREE Full text] [doi:
10.1055/s-0043-120195] [Medline: 30539109]
14. Jo E, Lewis K, Directo D, Kim MJ, Dolezal BA. Validation of biofeedback wearables for photoplethysmographic heart
rate tracking. J Sports Sci Med 2016 Sep;15(3):540-547 [FREE Full text] [Medline: 27803634]
15. Spierer DK, Rosen Z, Litman LL, Fujii K. Validation of photoplethysmography as a method to detect heart rate during rest
and exercise. J Med Eng Technol 2015 Jun 26;39(5):264-271. [doi: 10.3109/03091902.2015.1047536] [Medline: 26112379]
16. Johnson JM. Physical training and the control of skin blood flow. Med Sci Sports Exerc 1998 Mar;30(3):382-386. [doi:
10.1097/00005768-199803000-00007] [Medline: 9526883]
17. Craig CL, Marshall AL, Sjöström M, Bauman AE, Booth ML, Ainsworth BE, et al. International physical activity
questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 2003 Aug;35(8):1381-1395. [doi:
10.1249/01.MSS.0000078924.61453.FB] [Medline: 12900694]
18. Gilgen-Ammann R, Schweizer T, Wyss T. RR interval signal quality of a heart rate monitor and an ECG Holter at rest and
during exercise. Eur J Appl Physiol 2019 Jul 19;119(7):1525-1532. [doi: 10.1007/s00421-019-04142-5] [Medline: 31004219]
19. PulseWatch. URL: https://iccir919.github.io/pulseWatch/public/index.html [accessed 2021-03-05]
JMIR Mhealth Uhealth 2021 | vol. 9 | iss. 3 | e25313 | p. 11https://mhealth.jmir.org/2021/3/e25313
(page number not for citation purposes)
Muggeridge et alJMIR MHEALTH AND UHEALTH
XSL•FO
RenderX
20. Gellish RL, Goslin B, Olson R, McDonald A, Russi G, Moudgil V. Longitudinal modeling of the relationship between age
and maximal heart rate. Med Sci Sports Exerc 2007 May;39(5):822-829. [doi: 10.1097/mss.0b013e31803349c6] [Medline:
17468581]
21. Bland MJ, Altman D. Statistical methods for assessing agreement between two methods of clinical measurement. The
Lancet 1986 Feb;327(8476):307-310. [doi: 10.1016/s0140-6736(86)90837-8]
22. Shcherbina A, Mattsson C, Waggott D, Salisbury H, Christle J, Hastie T, et al. Accuracy in wrist-worn, sensor-based
measurements of heart rate and energy expenditure in a diverse cohort. J Pers Med 2017 May 24;7(2):3 [FREE Full text]
[doi: 10.3390/jpm7020003] [Medline: 28538708]
23. Wang R, Blackburn G, Desai M, Phelan D, Gillinov L, Houghtaling P, et al. Accuracy of wrist-worn heart rate monitors.
JAMA Cardiol 2017 Jan 01;2(1):104-106. [doi: 10.1001/jamacardio.2016.3340] [Medline: 27732703]
24. Dooley EE, Golaszewski NM, Bartholomew JB. Estimating accuracy at exercise intensities: a comparative study of
self-monitoring heart rate and physical activity wearable devices. JMIR Mhealth Uhealth 2017 Mar 16;5(3):e34 [FREE
Full text] [doi: 10.2196/mhealth.7043] [Medline: 28302596]
25. Dondzila CJ, Lewis CA, Lopez JR, Parker TM. Congruent accuracy of wrist-worn activity trackers during controlled and
free-living conditions. Int J Exerc Sci. 2018. URL: https://digitalcommons.wku.edu/cgi/viewcontent.
cgi?article=2251&context=ijes [accessed 2021-03-05]
26. Olstad BH, Zinner C. Validation of the Polar OH1 and M600 optical heart rate sensors during front crawl swim training.
PLoS One 2020;15(4) [FREE Full text] [doi: 10.1371/journal.pone.0231522] [Medline: 32298322]
27. Horton JF, Stergiou P, Fung T, Katz L. Comparison of Polar M600 optical heart rate and ECG heart rate during exercise.
Med Sci Sport Exerc 2017;49(12). [doi: 10.1249/mss.0000000000001388]
28. Haghayegh S, Khoshnevis S, Smolensky MH, Diller KR. Accuracy of PurePulse photoplethysmography technology of
Fitbit Charge 2 for assessment of heart rate during sleep. Chronobiol Int 2019 Jul 16;36(7):927-933. [doi:
10.1080/07420528.2019.1596947] [Medline: 30990098]
29. Tedesco S, Sica M, Garbay T, Barton J, OrFlynn B. A comprehensive comparison of commercial wrist- worn trackers in
a young cohort in a lab- environment. In: Proceedings of the IEEE International Conference on Pervasive Computing and
Communications Workshops (PerCom Workshops). 2018 Presented at: IEEE International Conference on Pervasive
Computing and Communications Workshops (PerCom Workshops); March 19-23, 2018; Athens, Greece. [doi:
10.1109/PERCOMW.2018.8480386]
30. Wallen MP, Gomersall SR, Keating SE, Wisløff U, Coombes JS. Accuracy of heart rate watches: implications for weight
management. PLoS One 2016 May 27;11(5) [FREE Full text] [doi: 10.1371/journal.pone.0154420] [Medline: 27232714]
31. Mühlen JM, Stang J, Skovgaard LE, Judice PB, Molina-Garcia P, Johnston W, et al. Recommendations for determining
the validity of consumer wearable heart rate devices: expert statement and checklist of the INTERLIVE Network. Br J
Sports Med 2021 Jan 04 [FREE Full text] [doi: 10.1136/bjsports-2020-103148] [Medline: 33397674]
32. Sañudo B, De Hoyo M, Muñoz-López A, Perry J, Abt G. Pilot study assessing the influence of skin type on the heart rate
measurements obtained by photoplethysmography with the apple watch. J Med Syst 2019 May 22;43(7):195. [doi:
10.1007/s10916-019-1325-2] [Medline: 31119387]
33. Butler MJ, Crowe JA, Hayes-Gill BR, Rodmell PI. Motion limitations of non-contact photoplethysmography due to the
optical and topological properties of skin. Physiol Meas 2016 Apr 21;37(5):N27-N37. [doi: 10.1088/0967-3334/37/5/n27]
Abbreviations
ANS: autonomic nervous system
ECG: electrocardiogram
HIIE: high-intensity interval exercise
HR: heart rate
IPAQ-SF: International Physical Activity Questionnaire-Short Form
LoA: limits of agreement
MAPE: mean absolute percentage error
PPG: photoplethysmography
SIE: sprint interval exercise
JMIR Mhealth Uhealth 2021 | vol. 9 | iss. 3 | e25313 | p. 12https://mhealth.jmir.org/2021/3/e25313
(page number not for citation purposes)
Muggeridge et alJMIR MHEALTH AND UHEALTH
XSL•FO
RenderX
Edited by L Buis; submitted 27.10.20; peer-reviewed by G Abt, A Samuel; comments to author 06.12.20; revised version received
08.01.21; accepted 18.02.21; published 25.03.21
Please cite as:
Muggeridge DJ, Hickson K, Davies AV, Giggins OM, Megson IL, Gorely T, Crabtree DR
Measurement of Heart Rate Using the Polar OH1 and Fitbit Charge 3 Wearable Devices in Healthy Adults During Light, Moderate,
Vigorous, and Sprint-Based Exercise: Validation Study




©David Joseph Muggeridge, Kirsty Hickson, Aimie Victoria Davies, Oonagh M Giggins, Ian L Megson, Trish Gorely, Daniel
R Crabtree. Originally published in JMIR mHealth and uHealth (http://mhealth.jmir.org), 25.03.2021. This is an open-access
article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/),
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR
mHealth and uHealth, is properly cited. The complete bibliographic information, a link to the original publication on
http://mhealth.jmir.org/, as well as this copyright and license information must be included.
JMIR Mhealth Uhealth 2021 | vol. 9 | iss. 3 | e25313 | p. 13https://mhealth.jmir.org/2021/3/e25313
(page number not for citation purposes)
Muggeridge et alJMIR MHEALTH AND UHEALTH
XSL•FO
RenderX
